Literature DB >> 21258059

The changing pattern of referral in acute kidney injury.

T Ali1, A Tachibana, I Khan, J Townend, G J Prescott, W C Smith, W Simpson, A Macleod.   

Abstract

BACKGROUND: Acute kidney injury (AKI) is not only managed by nephrologists, but also by several other subspecialists. The referral rate to nephrologists and the factors influencing it are unknown. AIMS: To determine the referral rate, factors affecting referral and outcomes across the spectrum of AKI in a population based study.
METHODS: We identified all patients with serum creatinine concentrations ≥150 µmol/l (male) or ≥130 µmol/l (female) over a 6-month period. AKI was defined according to the RIFLE classification (risk, injury, failure, loss, end stage renal disease [ESRD]). Clinical information and outcomes were obtained from each patient's case records.
RESULTS: A total of 562 patients were identified as having AKI (incidence 2147 per million population/year [pmp/y]). One hundred and sixty-four patients (29%) were referred to nephrologists-referral rate 627 pmp/y. Forty-nine percent of patients whose serum creatinine rose to >300 µmol/l were referred compared with 22% in our previous study of 1997. Forty-eight patients required renal replacement therapy-incidence 184 pmp/y in comparison to 50 pmp/y in our previous study of 1997. Patients had higher odds of referral if they were male, of younger age and were in the F category of the RIFLE classification. Patients had lower odds of referral if they had multiple co-morbid conditions or if they were managed in a hospital without a nephrology service.
CONCLUSION: There has been a significant rise in the referral rate of patients with AKI to nephrologists but even during our period of study only one-third of such patients were being referred. With rising incidence and increased awareness, the referral rate will certainly rise putting a significant burden on the nephrology services.
© The Author 2011. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21258059     DOI: 10.1093/qjmed/hcq250

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  6 in total

1.  Outcomes from massive paracetamol overdose: a retrospective observational study.

Authors:  Daniel J B Marks; Paul I Dargan; John R H Archer; Charlotte L Davies; Alison M Dines; David M Wood; Shaun L Greene
Journal:  Br J Clin Pharmacol       Date:  2017-01-25       Impact factor: 4.335

2.  Trends in acute kidney injury, associated use of dialysis, and mortality after cardiac surgery, 1999 to 2008.

Authors:  Colin R Lenihan; Maria E Montez-Rath; Christina T Mora Mangano; Glenn M Chertow; Wolfgang C Winkelmayer
Journal:  Ann Thorac Surg       Date:  2012-12-25       Impact factor: 4.330

3.  National trends in acute kidney injury requiring dialysis in England between 1998 and 2013.

Authors:  Nitin V Kolhe; Andrew W Muirhead; Sally R Wilkes; Richard J Fluck; Maarten W Taal
Journal:  Kidney Int       Date:  2015-07-29       Impact factor: 10.612

4.  A modified Delphi process to identify process of care indicators for the identification, prevention and management of acute kidney injury after major surgery.

Authors:  Matthew T James; Neesh Pannu; Rebecca Barry; Divya Karsanji; Marcello Tonelli; Brenda R Hemmelgarn; Braden J Manns; Sean M Bagshaw; H Tom Stelfox; Elijah Dixon
Journal:  Can J Kidney Health Dis       Date:  2015-04-09

5.  Incidence, Severity, and Outcomes of Acute Kidney Injury in Octogenarians following Heart Valve Replacement Surgery.

Authors:  Michael A Mao; Charat Thongprayoon; YiFan Wu; Vickram Tejwani; Myriam Vela-Ortiz; Joseph Dearani; Qi Qian
Journal:  Int J Nephrol       Date:  2015-05-24

6.  Pediatric continuous renal replacement therapy: have practice changes changed outcomes? A large single-center ten-year retrospective evaluation.

Authors:  Alyssa A Riley; Mary Watson; Carolyn Smith; Danielle Guffey; Charles G Minard; Helen Currier; Ayse Akcan Arikan
Journal:  BMC Nephrol       Date:  2018-10-19       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.